Tumors of various grades and types inclduing ovarian, breast, bladder, NSCLC have shown better sensitivity to chemotherapy when their p53 is mutated while their p53 wildtype counterparts showed less or no response to treatment [112,113,114,115,116,117]. Here, TP53 is linked to non-small cell lung carcinoma.